Global Contraceptives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 139
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Contraceptives market size was valued at USD 1967.2 million in 2023 and is forecast to a readjusted size of USD 2321.3 million by 2030 with a CAGR of 2.4% during review period.
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
The Global Info Research report includes an overview of the development of the Contraceptives industry chain, the market status of 15–24 years (Pills, Injectable), 25–34 years (Pills, Injectable), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Contraceptives.
Regionally, the report analyzes the Contraceptives markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Contraceptives market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Contraceptives market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Contraceptives industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Units), revenue generated, and market share of different by Type (e.g., Pills, Injectable).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Contraceptives market.
Regional Analysis: The report involves examining the Contraceptives market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Contraceptives market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Contraceptives:
Company Analysis: Report covers individual Contraceptives manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Contraceptives This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (15–24 years, 25–34 years).
Technology Analysis: Report covers specific technologies relevant to Contraceptives. It assesses the current state, advancements, and potential future developments in Contraceptives areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Contraceptives market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Contraceptives market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value.
Market segment by Type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
Market segment by End User
15–24 years
25–34 years
35–44 years
Above 44 years
Major players covered
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contraceptives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Contraceptives, with price, sales, revenue and global market share of Contraceptives from 2019 to 2024.
Chapter 3, the Contraceptives competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contraceptives breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and end user, with sales market share and growth rate by type, end user, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Contraceptives market forecast, by regions, type and end user, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Contraceptives.
Chapter 14 and 15, to describe Contraceptives sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Contraceptives
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Contraceptives Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Pills
1.3.3 Injectable
1.3.4 Condoms
1.3.5 Vaginal Rings
1.3.6 IUDs
1.3.7 Subdermal Implants
1.3.8 Others
1.4 Market Analysis by End User
1.4.1 Overview: Global Contraceptives Consumption Value by End User: 2019 Versus 2023 Versus 2030
1.4.2 15–24 years
1.4.3 25–34 years
1.4.4 35–44 years
1.4.5 Above 44 years
1.5 Global Contraceptives Market Size & Forecast
1.5.1 Global Contraceptives Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Contraceptives Sales Quantity (2019-2030)
1.5.3 Global Contraceptives Average Price (2019-2030)
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Contraceptives Product and Services
2.1.4 Bayer AG Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer AG Recent Developments/Updates
2.2 Pfizer, Inc
2.2.1 Pfizer, Inc Details
2.2.2 Pfizer, Inc Major Business
2.2.3 Pfizer, Inc Contraceptives Product and Services
2.2.4 Pfizer, Inc Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer, Inc Recent Developments/Updates
2.3 Teva Pharmaceutical Industries Ltd
2.3.1 Teva Pharmaceutical Industries Ltd Details
2.3.2 Teva Pharmaceutical Industries Ltd Major Business
2.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Product and Services
2.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.4 Merck & Co., Inc
2.4.1 Merck & Co., Inc Details
2.4.2 Merck & Co., Inc Major Business
2.4.3 Merck & Co., Inc Contraceptives Product and Services
2.4.4 Merck & Co., Inc Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck & Co., Inc Recent Developments/Updates
2.5 Actavis, Inc.
2.5.1 Actavis, Inc. Details
2.5.2 Actavis, Inc. Major Business
2.5.3 Actavis, Inc. Contraceptives Product and Services
2.5.4 Actavis, Inc. Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Actavis, Inc. Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Contraceptives Product and Services
2.6.4 Johnson & Johnson Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Gedeon Richter
2.7.1 Gedeon Richter Details
2.7.2 Gedeon Richter Major Business
2.7.3 Gedeon Richter Contraceptives Product and Services
2.7.4 Gedeon Richter Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Gedeon Richter Recent Developments/Updates
2.8 Novo Nordisk A/S
2.8.1 Novo Nordisk A/S Details
2.8.2 Novo Nordisk A/S Major Business
2.8.3 Novo Nordisk A/S Contraceptives Product and Services
2.8.4 Novo Nordisk A/S Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novo Nordisk A/S Recent Developments/Updates
2.9 ZiZhu
2.9.1 ZiZhu Details
2.9.2 ZiZhu Major Business
2.9.3 ZiZhu Contraceptives Product and Services
2.9.4 ZiZhu Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ZiZhu Recent Developments/Updates
2.10 Baijingyu
2.10.1 Baijingyu Details
2.10.2 Baijingyu Major Business
2.10.3 Baijingyu Contraceptives Product and Services
2.10.4 Baijingyu Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Baijingyu Recent Developments/Updates
2.11 Huazhong
2.11.1 Huazhong Details
2.11.2 Huazhong Major Business
2.11.3 Huazhong Contraceptives Product and Services
2.11.4 Huazhong Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Huazhong Recent Developments/Updates
2.12 Sine
2.12.1 Sine Details
2.12.2 Sine Major Business
2.12.3 Sine Contraceptives Product and Services
2.12.4 Sine Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sine Recent Developments/Updates
2.13 Reckitt
2.13.1 Reckitt Details
2.13.2 Reckitt Major Business
2.13.3 Reckitt Contraceptives Product and Services
2.13.4 Reckitt Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Reckitt Recent Developments/Updates
2.14 AbbVie
2.14.1 AbbVie Details
2.14.2 AbbVie Major Business
2.14.3 AbbVie Contraceptives Product and Services
2.14.4 AbbVie Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 AbbVie Recent Developments/Updates
2.15 Church & Dwight
2.15.1 Church & Dwight Details
2.15.2 Church & Dwight Major Business
2.15.3 Church & Dwight Contraceptives Product and Services
2.15.4 Church & Dwight Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Church & Dwight Recent Developments/Updates
2.16 The Cooper Companies
2.16.1 The Cooper Companies Details
2.16.2 The Cooper Companies Major Business
2.16.3 The Cooper Companies Contraceptives Product and Services
2.16.4 The Cooper Companies Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 The Cooper Companies Recent Developments/Updates
2.17 TherapeuticsMD
2.17.1 TherapeuticsMD Details
2.17.2 TherapeuticsMD Major Business
2.17.3 TherapeuticsMD Contraceptives Product and Services
2.17.4 TherapeuticsMD Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 TherapeuticsMD Recent Developments/Updates
2.18 Afaxys
2.18.1 Afaxys Details
2.18.2 Afaxys Major Business
2.18.3 Afaxys Contraceptives Product and Services
2.18.4 Afaxys Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Afaxys Recent Developments/Updates
2.19 Mithra Pharmaceuticals
2.19.1 Mithra Pharmaceuticals Details
2.19.2 Mithra Pharmaceuticals Major Business
2.19.3 Mithra Pharmaceuticals Contraceptives Product and Services
2.19.4 Mithra Pharmaceuticals Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Mithra Pharmaceuticals Recent Developments/Updates
3.1 Global Contraceptives Sales Quantity by Manufacturer (2019-2024)
3.2 Global Contraceptives Revenue by Manufacturer (2019-2024)
3.3 Global Contraceptives Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Contraceptives Manufacturer Market Share in 2023
3.4.2 Top 6 Contraceptives Manufacturer Market Share in 2023
3.5 Contraceptives Market: Overall Company Footprint Analysis
3.5.1 Contraceptives Market: Region Footprint
3.5.2 Contraceptives Market: Company Product Type Footprint
3.5.3 Contraceptives Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Contraceptives Market Size by Region
4.1.1 Global Contraceptives Sales Quantity by Region (2019-2030)
4.1.2 Global Contraceptives Consumption Value by Region (2019-2030)
4.1.3 Global Contraceptives Average Price by Region (2019-2030)
4.2 North America Contraceptives Consumption Value (2019-2030)
4.3 Europe Contraceptives Consumption Value (2019-2030)
4.4 Asia-Pacific Contraceptives Consumption Value (2019-2030)
4.5 South America Contraceptives Consumption Value (2019-2030)
4.6 Middle East and Africa Contraceptives Consumption Value (2019-2030)
5.1 Global Contraceptives Sales Quantity by Type (2019-2030)
5.2 Global Contraceptives Consumption Value by Type (2019-2030)
5.3 Global Contraceptives Average Price by Type (2019-2030)
6.1 Global Contraceptives Sales Quantity by End User (2019-2030)
6.2 Global Contraceptives Consumption Value by End User (2019-2030)
6.3 Global Contraceptives Average Price by End User (2019-2030)
7.1 North America Contraceptives Sales Quantity by Type (2019-2030)
7.2 North America Contraceptives Sales Quantity by End User (2019-2030)
7.3 North America Contraceptives Market Size by Country
7.3.1 North America Contraceptives Sales Quantity by Country (2019-2030)
7.3.2 North America Contraceptives Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Contraceptives Sales Quantity by Type (2019-2030)
8.2 Europe Contraceptives Sales Quantity by End User (2019-2030)
8.3 Europe Contraceptives Market Size by Country
8.3.1 Europe Contraceptives Sales Quantity by Country (2019-2030)
8.3.2 Europe Contraceptives Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Contraceptives Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Contraceptives Sales Quantity by End User (2019-2030)
9.3 Asia-Pacific Contraceptives Market Size by Region
9.3.1 Asia-Pacific Contraceptives Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Contraceptives Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Contraceptives Sales Quantity by Type (2019-2030)
10.2 South America Contraceptives Sales Quantity by End User (2019-2030)
10.3 South America Contraceptives Market Size by Country
10.3.1 South America Contraceptives Sales Quantity by Country (2019-2030)
10.3.2 South America Contraceptives Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Contraceptives Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Contraceptives Sales Quantity by End User (2019-2030)
11.3 Middle East & Africa Contraceptives Market Size by Country
11.3.1 Middle East & Africa Contraceptives Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Contraceptives Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Contraceptives Market Drivers
12.2 Contraceptives Market Restraints
12.3 Contraceptives Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Contraceptives and Key Manufacturers
13.2 Manufacturing Costs Percentage of Contraceptives
13.3 Contraceptives Production Process
13.4 Contraceptives Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Contraceptives Typical Distributors
14.3 Contraceptives Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Contraceptives Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Contraceptives Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Table 3. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 4. Bayer AG Major Business
Table 5. Bayer AG Contraceptives Product and Services
Table 6. Bayer AG Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bayer AG Recent Developments/Updates
Table 8. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer, Inc Major Business
Table 10. Pfizer, Inc Contraceptives Product and Services
Table 11. Pfizer, Inc Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer, Inc Recent Developments/Updates
Table 13. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Industries Ltd Major Business
Table 15. Teva Pharmaceutical Industries Ltd Contraceptives Product and Services
Table 16. Teva Pharmaceutical Industries Ltd Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 18. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co., Inc Major Business
Table 20. Merck & Co., Inc Contraceptives Product and Services
Table 21. Merck & Co., Inc Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Merck & Co., Inc Recent Developments/Updates
Table 23. Actavis, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Actavis, Inc. Major Business
Table 25. Actavis, Inc. Contraceptives Product and Services
Table 26. Actavis, Inc. Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Actavis, Inc. Recent Developments/Updates
Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 29. Johnson & Johnson Major Business
Table 30. Johnson & Johnson Contraceptives Product and Services
Table 31. Johnson & Johnson Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Johnson & Johnson Recent Developments/Updates
Table 33. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 34. Gedeon Richter Major Business
Table 35. Gedeon Richter Contraceptives Product and Services
Table 36. Gedeon Richter Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Gedeon Richter Recent Developments/Updates
Table 38. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 39. Novo Nordisk A/S Major Business
Table 40. Novo Nordisk A/S Contraceptives Product and Services
Table 41. Novo Nordisk A/S Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Novo Nordisk A/S Recent Developments/Updates
Table 43. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 44. ZiZhu Major Business
Table 45. ZiZhu Contraceptives Product and Services
Table 46. ZiZhu Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. ZiZhu Recent Developments/Updates
Table 48. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 49. Baijingyu Major Business
Table 50. Baijingyu Contraceptives Product and Services
Table 51. Baijingyu Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Baijingyu Recent Developments/Updates
Table 53. Huazhong Basic Information, Manufacturing Base and Competitors
Table 54. Huazhong Major Business
Table 55. Huazhong Contraceptives Product and Services
Table 56. Huazhong Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Huazhong Recent Developments/Updates
Table 58. Sine Basic Information, Manufacturing Base and Competitors
Table 59. Sine Major Business
Table 60. Sine Contraceptives Product and Services
Table 61. Sine Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Sine Recent Developments/Updates
Table 63. Reckitt Basic Information, Manufacturing Base and Competitors
Table 64. Reckitt Major Business
Table 65. Reckitt Contraceptives Product and Services
Table 66. Reckitt Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Reckitt Recent Developments/Updates
Table 68. AbbVie Basic Information, Manufacturing Base and Competitors
Table 69. AbbVie Major Business
Table 70. AbbVie Contraceptives Product and Services
Table 71. AbbVie Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. AbbVie Recent Developments/Updates
Table 73. Church & Dwight Basic Information, Manufacturing Base and Competitors
Table 74. Church & Dwight Major Business
Table 75. Church & Dwight Contraceptives Product and Services
Table 76. Church & Dwight Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Church & Dwight Recent Developments/Updates
Table 78. The Cooper Companies Basic Information, Manufacturing Base and Competitors
Table 79. The Cooper Companies Major Business
Table 80. The Cooper Companies Contraceptives Product and Services
Table 81. The Cooper Companies Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. The Cooper Companies Recent Developments/Updates
Table 83. TherapeuticsMD Basic Information, Manufacturing Base and Competitors
Table 84. TherapeuticsMD Major Business
Table 85. TherapeuticsMD Contraceptives Product and Services
Table 86. TherapeuticsMD Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. TherapeuticsMD Recent Developments/Updates
Table 88. Afaxys Basic Information, Manufacturing Base and Competitors
Table 89. Afaxys Major Business
Table 90. Afaxys Contraceptives Product and Services
Table 91. Afaxys Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Afaxys Recent Developments/Updates
Table 93. Mithra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 94. Mithra Pharmaceuticals Major Business
Table 95. Mithra Pharmaceuticals Contraceptives Product and Services
Table 96. Mithra Pharmaceuticals Contraceptives Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Mithra Pharmaceuticals Recent Developments/Updates
Table 98. Global Contraceptives Sales Quantity by Manufacturer (2019-2024) & (M Units)
Table 99. Global Contraceptives Revenue by Manufacturer (2019-2024) & (USD Million)
Table 100. Global Contraceptives Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 101. Market Position of Manufacturers in Contraceptives, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 102. Head Office and Contraceptives Production Site of Key Manufacturer
Table 103. Contraceptives Market: Company Product Type Footprint
Table 104. Contraceptives Market: Company Product Application Footprint
Table 105. Contraceptives New Market Entrants and Barriers to Market Entry
Table 106. Contraceptives Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Contraceptives Sales Quantity by Region (2019-2024) & (M Units)
Table 108. Global Contraceptives Sales Quantity by Region (2025-2030) & (M Units)
Table 109. Global Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
Table 110. Global Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
Table 111. Global Contraceptives Average Price by Region (2019-2024) & (USD/Unit)
Table 112. Global Contraceptives Average Price by Region (2025-2030) & (USD/Unit)
Table 113. Global Contraceptives Sales Quantity by Type (2019-2024) & (M Units)
Table 114. Global Contraceptives Sales Quantity by Type (2025-2030) & (M Units)
Table 115. Global Contraceptives Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Global Contraceptives Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Global Contraceptives Average Price by Type (2019-2024) & (USD/Unit)
Table 118. Global Contraceptives Average Price by Type (2025-2030) & (USD/Unit)
Table 119. Global Contraceptives Sales Quantity by End User (2019-2024) & (M Units)
Table 120. Global Contraceptives Sales Quantity by End User (2025-2030) & (M Units)
Table 121. Global Contraceptives Consumption Value by End User (2019-2024) & (USD Million)
Table 122. Global Contraceptives Consumption Value by End User (2025-2030) & (USD Million)
Table 123. Global Contraceptives Average Price by End User (2019-2024) & (USD/Unit)
Table 124. Global Contraceptives Average Price by End User (2025-2030) & (USD/Unit)
Table 125. North America Contraceptives Sales Quantity by Type (2019-2024) & (M Units)
Table 126. North America Contraceptives Sales Quantity by Type (2025-2030) & (M Units)
Table 127. North America Contraceptives Sales Quantity by End User (2019-2024) & (M Units)
Table 128. North America Contraceptives Sales Quantity by End User (2025-2030) & (M Units)
Table 129. North America Contraceptives Sales Quantity by Country (2019-2024) & (M Units)
Table 130. North America Contraceptives Sales Quantity by Country (2025-2030) & (M Units)
Table 131. North America Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
Table 132. North America Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Europe Contraceptives Sales Quantity by Type (2019-2024) & (M Units)
Table 134. Europe Contraceptives Sales Quantity by Type (2025-2030) & (M Units)
Table 135. Europe Contraceptives Sales Quantity by End User (2019-2024) & (M Units)
Table 136. Europe Contraceptives Sales Quantity by End User (2025-2030) & (M Units)
Table 137. Europe Contraceptives Sales Quantity by Country (2019-2024) & (M Units)
Table 138. Europe Contraceptives Sales Quantity by Country (2025-2030) & (M Units)
Table 139. Europe Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific Contraceptives Sales Quantity by Type (2019-2024) & (M Units)
Table 142. Asia-Pacific Contraceptives Sales Quantity by Type (2025-2030) & (M Units)
Table 143. Asia-Pacific Contraceptives Sales Quantity by End User (2019-2024) & (M Units)
Table 144. Asia-Pacific Contraceptives Sales Quantity by End User (2025-2030) & (M Units)
Table 145. Asia-Pacific Contraceptives Sales Quantity by Region (2019-2024) & (M Units)
Table 146. Asia-Pacific Contraceptives Sales Quantity by Region (2025-2030) & (M Units)
Table 147. Asia-Pacific Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
Table 148. Asia-Pacific Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
Table 149. South America Contraceptives Sales Quantity by Type (2019-2024) & (M Units)
Table 150. South America Contraceptives Sales Quantity by Type (2025-2030) & (M Units)
Table 151. South America Contraceptives Sales Quantity by End User (2019-2024) & (M Units)
Table 152. South America Contraceptives Sales Quantity by End User (2025-2030) & (M Units)
Table 153. South America Contraceptives Sales Quantity by Country (2019-2024) & (M Units)
Table 154. South America Contraceptives Sales Quantity by Country (2025-2030) & (M Units)
Table 155. South America Contraceptives Consumption Value by Country (2019-2024) & (USD Million)
Table 156. South America Contraceptives Consumption Value by Country (2025-2030) & (USD Million)
Table 157. Middle East & Africa Contraceptives Sales Quantity by Type (2019-2024) & (M Units)
Table 158. Middle East & Africa Contraceptives Sales Quantity by Type (2025-2030) & (M Units)
Table 159. Middle East & Africa Contraceptives Sales Quantity by End User (2019-2024) & (M Units)
Table 160. Middle East & Africa Contraceptives Sales Quantity by End User (2025-2030) & (M Units)
Table 161. Middle East & Africa Contraceptives Sales Quantity by Region (2019-2024) & (M Units)
Table 162. Middle East & Africa Contraceptives Sales Quantity by Region (2025-2030) & (M Units)
Table 163. Middle East & Africa Contraceptives Consumption Value by Region (2019-2024) & (USD Million)
Table 164. Middle East & Africa Contraceptives Consumption Value by Region (2025-2030) & (USD Million)
Table 165. Contraceptives Raw Material
Table 166. Key Manufacturers of Contraceptives Raw Materials
Table 167. Contraceptives Typical Distributors
Table 168. Contraceptives Typical Customers
List of Figures
Figure 1. Contraceptives Picture
Figure 2. Global Contraceptives Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Contraceptives Consumption Value Market Share by Type in 2023
Figure 4. Pills Examples
Figure 5. Injectable Examples
Figure 6. Condoms Examples
Figure 7. Vaginal Rings Examples
Figure 8. IUDs Examples
Figure 9. Subdermal Implants Examples
Figure 10. Others Examples
Figure 11. Global Contraceptives Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Figure 12. Global Contraceptives Consumption Value Market Share by End User in 2023
Figure 13. 15–24 years Examples
Figure 14. 25–34 years Examples
Figure 15. 35–44 years Examples
Figure 16. Above 44 years Examples
Figure 17. Global Contraceptives Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Contraceptives Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Contraceptives Sales Quantity (2019-2030) & (M Units)
Figure 20. Global Contraceptives Average Price (2019-2030) & (USD/Unit)
Figure 21. Global Contraceptives Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Contraceptives Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Contraceptives by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Contraceptives Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Contraceptives Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Contraceptives Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Contraceptives Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Contraceptives Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Contraceptives Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Contraceptives Average Price by Type (2019-2030) & (USD/Unit)
Figure 36. Global Contraceptives Sales Quantity Market Share by End User (2019-2030)
Figure 37. Global Contraceptives Consumption Value Market Share by End User (2019-2030)
Figure 38. Global Contraceptives Average Price by End User (2019-2030) & (USD/Unit)
Figure 39. North America Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Contraceptives Sales Quantity Market Share by End User (2019-2030)
Figure 41. North America Contraceptives Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Contraceptives Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Contraceptives Sales Quantity Market Share by End User (2019-2030)
Figure 48. Europe Contraceptives Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Contraceptives Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Contraceptives Sales Quantity Market Share by End User (2019-2030)
Figure 57. Asia-Pacific Contraceptives Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Contraceptives Consumption Value Market Share by Region (2019-2030)
Figure 59. China Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Contraceptives Sales Quantity Market Share by End User (2019-2030)
Figure 67. South America Contraceptives Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Contraceptives Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Contraceptives Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Contraceptives Sales Quantity Market Share by End User (2019-2030)
Figure 73. Middle East & Africa Contraceptives Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Contraceptives Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Contraceptives Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Contraceptives Market Drivers
Figure 80. Contraceptives Market Restraints
Figure 81. Contraceptives Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Contraceptives in 2023
Figure 84. Manufacturing Process Analysis of Contraceptives
Figure 85. Contraceptives Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Bayer AG Pfizer, Inc Teva Pharmaceutical Industries Ltd Merck & Co., Inc Actavis, Inc. Johnson & Johnson Gedeon Richter Novo Nordisk A/S ZiZhu Baijingyu Huazhong Sine Reckitt AbbVie Church & Dwight The Cooper Companies TherapeuticsMD Afaxys Mithra Pharmaceuticals
Related Reports
25 Nov 2021
Pharma & Healthcare
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
